Deletion of Cardiac PAD2 Causes Diastolic Dysfunction in the Female Heart

Heart failure is a leading cause of death and disability worldwide, with aging women more likely than aging men to develop diastolic dysfunction (heart failure with preserved ejection fraction, HFpEF), for which no therapies currently exist. Post-translational modifications of cardiac proteins, such as citrullination catalyzed by peptidyl arginine deiminase 2 (PAD2), regulate diastolic function. Recent work from our group demonstrates that PAD2 expression robustly declines with age in the female heart and global deletion of PAD2 causes diastolic dysfunction in middle-aged female mice. To further investigate the consequences of loss of PAD2 in the female heart, we generated a novel model of inducible cardiac specific PAD2 knockout (PAD2 cKO). We hypothesized that deletion of cardiac PAD2 in the female heart would lead to diastolic dysfunction. To quantify heart function, we utilized echocardiography to assess early to late left ventricular filling (E/A), isovolumic relaxation time (IVRT), and ejection fraction (EF). Consistent with our hypothesis, young female PAD2 cKO mice showed a reduction in E/A with prolonged IVRT and a preserved EF compared to wild-type (WT) mice. Together, we propose that loss of PAD2 is a novel mechanism of diastolic dysfunction in the female heart. Ongoing work aims to identify the effects of cardiac PAD2 deletion in middle-aged and aged female mice. Future studies will also investigate the mechanisms associated with the loss of PAD2 expression and seek to understand how PAD2 regulates relaxation in the heart. Understanding the mechanism of PAD2 regulation may prove beneficial in the identification of HFpEF therapies for aging women. Wyoming Research Scholar Program, IDeA Networks for Biomedical Research Excellence This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Authors

Institutions

Publication Details

Journal
Physiology
Published
2025-05-01
DOI
https://doi.org/10.1152/physiol.2025.40.s1.1273
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deletion of Cardiac PAD2 Causes Diastolic Dysfunction in the Female Heart

Samantha K. Shorthill, Danielle R. Bruns, M Schmitt, Brian D. Cherrington et al.
Physiology
Cardiovascular Function and Risk Factors
article

Deletion of Cardiac PAD2 Causes Diastolic Dysfunction in the Female Heart

Samantha K. Shorthill, Danielle R. Bruns, M Schmitt, Brian D. Cherrington, Joshua Thornburg, Finley Klinger, Mason H. Agor
article en

Abstract

Heart failure is a leading cause of death and disability worldwide, with aging women more likely than aging men to develop diastolic dysfunction (heart failure with preserved ejection fraction, HFpEF), for which no therapies currently exist. Post-translational modifications of cardiac proteins, such as citrullination catalyzed by peptidyl arginine deiminase 2 (PAD2), regulate diastolic function. Recent work from our group demonstrates that PAD2 expression robustly declines with age in the female heart and global deletion of PAD2 causes diastolic dysfunction in middle-aged female mice. To further investigate the consequences of loss of PAD2 in the female heart, we generated a novel model of inducible cardiac specific PAD2 knockout (PAD2 cKO). We hypothesized that deletion of cardiac PAD2 in the female heart would lead to diastolic dysfunction. To quantify heart function, we utilized echocardiography to assess early to late left ventricular filling (E/A), isovolumic relaxation time (IVRT), and ejection fraction (EF). Consistent with our hypothesis, young female PAD2 cKO mice showed a reduction in E/A with prolonged IVRT and a preserved EF compared to wild-type (WT) mice. Together, we propose that loss of PAD2 is a novel mechanism of diastolic dysfunction in the female heart. Ongoing work aims to identify the effects of cardiac PAD2 deletion in middle-aged and aged female mice. Future studies will also investigate the mechanisms associated with the loss of PAD2 expression and seek to understand how PAD2 regulates relaxation in the heart. Understanding the mechanism of PAD2 regulation may prove beneficial in the identification of HFpEF therapies for aging women. Wyoming Research Scholar Program, IDeA Networks for Biomedical Research Excellence This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

PhysiologyVol. 40(S1)
University of Wyoming (US), Wyoming Department of Education (US)
Openalex Percentile: Top 73%
Cardiovascular Function and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.